Good evening :)
Place Order
Add to Watchlist

Syschem (India) Ltd

SYSCHEM

Syschem (India) Ltd

SYSCHEM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹199 cr, stock is ranked 2,516
High RiskStock is 3.37x as volatile as Nifty
47.904.39% (-2.20)
47.904.39% (-2.20)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹199 cr, stock is ranked 2,516
High RiskStock is 3.37x as volatile as Nifty
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹199 cr, stock is ranked 2,516
High RiskStock is 3.37x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-376.823.51
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.726.720.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Syschem India is engaged in the business of manufacturing of active pharmaceutical ingredients/intermediates. It's main products/services are Solvents, and Cephalosporins & preparations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 20.18%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.04% to 0.06%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 29.77%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue3.6612.5466.5193.1977.0274.6765.76130.63233.65253.67
Raw Materialssubtract3.4810.4361.5985.6367.1655.4246.9792.46197.91249.93
Power & Fuel Costsubtract0.570.521.601.571.892.872.392.152.84
Employee Costsubtract0.240.612.472.962.994.104.544.406.08
Selling & Administrative Expensessubtract0.210.310.701.001.668.478.4118.3037.32
Operating & Other expensessubtract0.020.72-2.68-1.633.348.722.764.42-17.65
Depreciation/Amortizationsubtract2.162.052.082.152.152.352.582.702.792.77
Interest & Other Itemssubtract0.010.030.150.010.020.060.280.040.250.15
Taxes & Other Itemssubtract-0.81-0.650.260.75-0.35-1.75-0.471.641.351.35
EPS-0.23-0.160.190.39-0.90-2.54-0.701.500.74-0.13
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Syschem (India) Ltd72.363.51
Sun Pharmaceutical Industries Ltd46.636.650.73%
Cipla Ltd29.524.540.86%
Mankind Pharma Ltd61.9412.37

Price Comparison

Compare SYSCHEM with any stock or ETF
Compare SYSCHEM with any stock or ETF
SYSCHEM
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding53.17%0.00%0.20%0.00%46.63%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

SepNovDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

SYSCHEM has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Syschem (India) EGM scheduled

Syschem (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 20 January 2025.Powered by Capital Market - Live

4 days agoCapital Market - Live
Corporate
Syschem (India) declare Quarterly Result

Syschem (India) will hold a meeting of the Board of Directors of the Company on 24 December 2024.Powered by Capital Market - Live

1 week agoCapital Market - Live
Earnings
Syschem (India) reports standalone net loss of Rs 0.64 crore in the September 2024 quarter

Net loss of Syschem (India) reported to Rs 0.64 crore in the quarter ended September 2024 as against net profit of Rs 1.12 crore during the previous quarter ended September 2023. Sales rose 28.05% to Rs 47.52 crore in the quarter ended September 2024 as against Rs 37.11 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales47.5237.11 28 OPM %0.154.99 - PBDT0.041.82 -98 PBT-0.641.12 PL NP-0.641.12 PL Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Syschem (India) schedules board meeting

Syschem (India) will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Syschem (India) standalone net profit declines 91.67% in the June 2024 quarter

Net profit of Syschem (India) declined 91.67% to Rs 0.14 crore in the quarter ended June 2024 as against Rs 1.68 crore during the previous quarter ended June 2023. Sales rose 103.09% to Rs 87.53 crore in the quarter ended June 2024 as against Rs 43.10 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales87.5343.10 103 OPM %0.935.71 - PBDT0.822.36 -65 PBT0.141.68 -92 NP0.141.68 -92 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Syschem (India) to announce Quarterly Result

Syschem (India) will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live

Stocks that will see action today: August 21, 2023

1 year agoThe Hindu Businessline

Syschem India share price gains 9% on capacity expansion plan

1 year agoMoneycontrol

Syschem India Standalone March 2023 Net Sales at Rs 56.91 crore, up 152.73% Y-o-Y

1 year agoMoneycontrol

Syschem India Standalone June 2021 Net Sales At Rs 19.55 Crore, Up 0% Y-o-Y

3 years agoMoneycontrol